Ameriprise
BHVN icon

Ameriprise’s Biohaven BHVN Stock Holding History

Ameriprise’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.99M Buy
268,227
+212,887
+385% +$2.29M ﹤0.01% 2699
2026
Q1 		$468K Buy
55,340
+1,292
+2% +$14.1K ﹤0.01% 3610
2025
Q4 		$610K Sell
54,048
-103,924
-66% -$1.29M ﹤0.01% 3550
2025
Q3 		$2.37M Sell
157,972
-23,883
-13% -$348K ﹤0.01% 2920
2025
Q2 		$2.57M Sell
181,855
-353,224
-66% -$6.3M ﹤0.01% 2807
2025
Q1 		$12.9M Buy
535,079
+26,397
+5% +$931K ﹤0.01% 1583
2024
Q4 		$19M Buy
508,682
+145,331
+40% +$6.78M ﹤0.01% 1368
2024
Q3 		$18.2M Buy
363,351
+100,201
+38% +$3.9M ﹤0.01% 1390
2024
Q2 		$9.13M Buy
263,150
+108,896
+71% +$4.31M ﹤0.01% 1822
2024
Q1 		$8.44M Buy
154,254
+108,540
+237% +$5.37M ﹤0.01% 1940
2023
Q4 		$1.96M Buy
45,714
+23,139
+102% +$720K ﹤0.01% 2884
2023
Q3 		$587K Buy
+22,575
New +$469K ﹤0.01% 3343

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ameriprise's BHVN Position: Q2 2026 in Review

Ameriprise increased its Biohaven (BHVN) stake by 385% in Q2 2026, buying an estimated $2.29M and bringing the position to 268,227 shares worth $3.99M. The position accounts for ﹤0.01% of the portfolio, ranked #2699.

Ameriprise first reported a position in BHVN in Q3 2023 and has held it in 12 quarters since. The position peaked at $19M in Q4 2024. 293 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Ameriprise held 268,227 shares of Biohaven worth $3.99M as of Q2 2026.
  • Ameriprise bought 212,887 Biohaven shares in Q2 2026, an estimated $2.29M.
  • Biohaven made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #2699 holding.
  • Ameriprise first reported a position in Biohaven in Q3 2023 and has held it in 12 quarters since.
  • Ameriprise's Biohaven position peaked at $19M in Q4 2024.
  • 293 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.